A new article in the peer-reviewed journal Nucleic Acid Therapeutics describes the characterization of antibodies targeting ...

A new article in the peer-reviewed journal Nucleic Acid Therapeutics describes the characterization of antibodies targeting ...

A new article in the peer-reviewed journal Nucleic Acid Therapeutics describes the characterization of antibodies targeting antisense oligonucleotide ...

With this in mind, we set out using our deep knowledge, expertise, and proprietary technologies to develop our ModDetect™ line, which consists of the very first antibody specialty reagent panels that ...

"It's a way to discover nucleic acid modifications that you didn't know existed," says Peter Dedon, the Underwood-Prescott Professor of Biological Engineering at MIT.

Still, recent advancements in modification techniques make nanoparticles an excellent and mature nucleic acid delivery technology, the author concluded.

Wave paper on PN chemistry for silencing in the CNS, and the implications for oligonucleotides more broadly, designated as a Breakthrough Article by Nucleic Acids Research Publications highlight ...

Nucleic Acid Therapeutics is under the editorial leadership of Co-Editors-in-Chief Bruce A. Sullenger, PhD, Duke Translational Research Institute, Duke University Medical Center, Durham, NC, and C ...

The market for synthetic nucleic acids has expanded to over $1.5 billion per year globally, but the demand is not always met with the existing service-focused business model.

Summary Peptide Nucleic Acid (PNA) is a synthetic polymer similar to DNA or RNA. PNA can be said to have been born in Denmark, where it was originally developed by Peter E. Nielsen (University of ...